127 related articles for article (PubMed ID: 33991632)
1. Green synthesis of therapeutically active 1,3,4-oxadiazoles as antioxidants, selective COX-2 inhibitors and their in silico studies.
Nesaragi AR; Kamble RR; Dixit S; Kodasi B; Hoolageri SR; Bayannavar PK; Dasappa JP; Vootla S; Joshi SD; Kumbar VM
Bioorg Med Chem Lett; 2021 Jul; 43():128112. PubMed ID: 33991632
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study.
Kashid BB; Salunkhe PH; Dongare BB; More KR; Khedkar VM; Ghanwat AA
Bioorg Med Chem Lett; 2020 Jun; 30(12):127136. PubMed ID: 32280025
[TBL] [Abstract][Full Text] [Related]
3. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Comprehensive Investigations of Pyrrolo[3,4-
Szczukowski Ł; Krzyżak E; Zborowska A; Zając P; Potyrak K; Peregrym K; Wiatrak B; Marciniak A; Świątek P
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348757
[TBL] [Abstract][Full Text] [Related]
5. Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis.
Kumar D; Kumar RR; Pathania S; Singh PK; Kalra S; Kumar B
Bioorg Chem; 2021 Sep; 114():105068. PubMed ID: 34130110
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity.
Bansal S; Bala M; Suthar SK; Choudhary S; Bhattacharya S; Bhardwaj V; Singla S; Joseph A
Eur J Med Chem; 2014 Jun; 80():167-74. PubMed ID: 24780593
[TBL] [Abstract][Full Text] [Related]
7. Design and one-pot and microwave-assisted synthesis of 2-amino/5-aryl-1,3,4-oxadiazoles bearing a benzimidazole moiety as antioxidants.
Kerimov İ; Ayhan-Kilcigil G; Özdamar ED; Can-Eke B; Çoban T; Özbey S; Kazak C
Arch Pharm (Weinheim); 2012 Jul; 345(7):549-56. PubMed ID: 22467524
[TBL] [Abstract][Full Text] [Related]
8. Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity.
Bhat MA; Al-Omar MA; Alsaif NA; Almehizia AA; Naglah AM; Razak S; Khan AA; Ashraf NM
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):921-934. PubMed ID: 32238055
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2.
Asati V; Ghode P; Bajaj S; Jain SK; Bharti SK
Curr Comput Aided Drug Des; 2019; 15(4):277-293. PubMed ID: 30280671
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antioxidant activity of styrylsulfonylmethyl 1,3,4-oxadiazoles, pyrazolyl/isoxazolyl-1,3,4-oxadiazoles.
Mallikarjuna Reddy G; Muralikrishna A; Padmavathi V; Padmaja A; Krishna Tilak T; Appa Rao C
Chem Pharm Bull (Tokyo); 2013; 61(12):1291-7. PubMed ID: 24292790
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
Bandgar BP; Adsul LK; Chavan HV; Jalde SS; Shringare SN; Shaikh R; Meshram RJ; Gacche RN; Masand V
Bioorg Med Chem Lett; 2012 Sep; 22(18):5839-44. PubMed ID: 22901385
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluations of novel isoxazoles and furoxan derivative as anti-inflammatory agents.
Abdelall EKA
Bioorg Chem; 2020 Jan; 94():103441. PubMed ID: 31859011
[TBL] [Abstract][Full Text] [Related]
14. Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy.
Ayoup MS; Abu-Serie MM; Abdel-Hamid H; Teleb M
Eur J Med Chem; 2021 Aug; 220():113475. PubMed ID: 33901898
[TBL] [Abstract][Full Text] [Related]
15. Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation.
Tietz O; Kaur J; Bhardwaj A; Wuest FR
Org Biomol Chem; 2016 Jul; 14(30):7250-7. PubMed ID: 27383140
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and bioassay of aminosulfonyl-1,3,4-oxadiazoles and their interconversion to 1,3,4-thiadiazoles.
Padmavathi V; Reddy SN; Reddy GD; Padmaja A
Eur J Med Chem; 2010 Sep; 45(9):4246-51. PubMed ID: 20630628
[TBL] [Abstract][Full Text] [Related]
17. Studies in 3,4-diaryl-1,2,5-oxadiazoles and their N-oxides: search for better COX-2 inhibitors.
Yadav MR; Shirude ST; Puntambekar DS; Patel PJ; Prajapati HB; Parmar A; Balaraman R; Giridhar R
Acta Pharm; 2007 Mar; 57(1):13-30. PubMed ID: 19839404
[TBL] [Abstract][Full Text] [Related]
18. Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
Kumar R; Saha N; Purohit P; Garg SK; Seth K; Meena VS; Dubey S; Dave K; Goyal R; Sharma SS; Banerjee UC; Chakraborti AK
Eur J Med Chem; 2019 Nov; 182():111601. PubMed ID: 31445233
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
20. Bioassay-guided isolation of cyclooxygenase-2 inhibitory and antioxidant phenylpropanoid derivatives from the roots of Dendropanax dentiger.
Yang L; Liu S; Liu R; He J
Bioorg Chem; 2020 Nov; 104():104211. PubMed ID: 32920357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
